Kennedy, Professor Colin
MD BCh FRCP FRCPCH
Training and education
- BA in philosophy, physiology and psychology (first class honours), University of Oxford.
- MBBS and MD, London.
- Medical Research Council (MRC) funded medical research fellow, Northwick Park Clinical Research Centre.
- Fellow in neurology, Johns Hopkins Hospital, USA.
- Joint UK accreditation in paediatrics and paediatric neurology.
Professor Kennedy is an honorary consultant in paediatric neurology and has worked for the Trust since 1984. Previously, he's worked at various London postgraduate hospitals (Hammersmith, National Queen Square, Northwick Park, Great Ormond Street) and was a lecturer on child health in Southampton.
In 1988 he set up the paediatric neurology service and was the clinical lead for over 24 years until 2012. His current role involves outpatient and inpatient clinical care and clinical research.
Professor Kennedy has a special interest in neuro-oncology. He has worked with UK and European groups that test new treatments in clinical trials, trying to ensure that assessment of the effects of treatments is not restricted to measuring survival rates but includes measurement of the quality of survival.
He also had a continuing 20 year programme of research into the effects of early intervention for permanent childhood hearing impairment. It has been instrumental in the adoption of universal newborn screening in every district of the UK, and has federal support for its adoption throughout the USA.
- Former president of the UK and European societies of his specialty (BPNA, EPNS).
- Became Chair of research support panel of Child Brain Research, UK.
- Worked with the World Health Organisation to improve paediatric neurology services in Kazakhstan.
Awards and prizes
- Dr Michael Blacow Award, British Paediatric Association (now the Royal College of Paediatrics and Child Health), for the best paper at annual scientific meeting.
- Donald Paterson Prize, BPA (now the RCPCH) for best published paper in preceding two years by a paediatrician in training.
Professor Kennedy has made significant contributions to literature on encephalitis, management of posthemorrhagic hydrocephalus of infants, universal newborn screening for permanent deafness, early brain tumour diagnosis and quality of survival following brain tumours.
Prof Kennedy's selected publications include:
- Pimperton H, Blythe H, Kreppner J, Mahon H, Peacock Jl, Stevenson JE, Terlektsi E, Worsfold SM, Yuen HM, Kennedy CR. The impact of universal newborn hearing screening on long-term literacy outcomes: a prospective cohort study. Arch Dis Child Published Online First: November 25, 2014 doi: 10.1136/archdischild-2014-307516
- Bull K, Liossi C, Culliford D, Peacock J, Kennedy C on behalf of the Children’s Cancer and Leukaemia Group (CCLG). Child-related characteristics predicting subsequent health-related quality of life in 8- to 14-year-old children with and without cerebellar tumors: a prospective longitudinal study, Neuro Oncol Pract (2014) 1 (3): 114-122
- Kennedy C, Bull K, Chevignard M, Culliford D, Dörr HG, Doz F, Kortmann R, Lannering B, Massimino M, Navajas Gutiérrez A, Spoudeas HA, Rutkowski S, Calaminus G on behalf of the PNET4 study group of the Brain Tumour Group of SIOP-Europe. Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyper-fractionated versus conventional radiotherapy for standard risk medulloblastoma. Int J Rad Oncol Biol Phys, (2014), 89: 292-300 DOI information: 10.1016/j.ijrobp.2013.09.0463o
- Bull KS, Kennedy CR, Bailey S, Ellison DE, Clifford SC. Improved health-related quality of life outcomes associated with SHH subgroup medulloblastoma in SIOP-UKCCSG PNET3 trial survivors. Acta Neuropathol (2014) 128: 151-153, published on-line 31/05/14. DOI 10.1007/s00401-014-1300-4
- J Clin Oncol, 2007, 25: 4239-4245; Arch Dis Child, 2009, 94: 293-297
- The Lancet Oncol, 2007, 8: 685-695; Pediatrics, 2007, 120: 1044-52
- N Engl J Med, 2006, 354: 2131-41; Pediatrics, 2007,120 e694-e701
- The Lancet Neurol 2005, 4: 712-17; Pediatrics 2006, 117: 1101-12
- The Lancet 2004, 364: 1773-78; The Lancet, 2005, 366: 660-662
- The Lancet 2000, 356; 1903-04; Pediatrics 2001,108: 597-607
- The Lancet 1998, 352:433-40; The Lancet, 1998, 352:1957-1964
- The Lancet 1986 i: 989 991; Clin Immun Immunopathol, 1987, 42:218 228